ATE96660T1 - Osmotische orale dosisform zur fertilitaetskontrolle. - Google Patents

Osmotische orale dosisform zur fertilitaetskontrolle.

Info

Publication number
ATE96660T1
ATE96660T1 AT91900649T AT91900649T ATE96660T1 AT E96660 T1 ATE96660 T1 AT E96660T1 AT 91900649 T AT91900649 T AT 91900649T AT 91900649 T AT91900649 T AT 91900649T AT E96660 T1 ATE96660 T1 AT E96660T1
Authority
AT
Austria
Prior art keywords
oral dose
dose form
fertility control
osmotic oral
female
Prior art date
Application number
AT91900649T
Other languages
English (en)
Inventor
Jeri Dawn Wright
Jerry D Childers
Brian L Barclay
Patrick S-L Wong
Linda E Atkinson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE96660T1 publication Critical patent/ATE96660T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Lubricants (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91900649T 1989-11-16 1990-11-12 Osmotische orale dosisform zur fertilitaetskontrolle. ATE96660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/437,480 US5098714A (en) 1989-11-16 1989-11-16 Osmotic, oral dosage form for fertility control
PCT/US1990/006588 WO1991007173A1 (en) 1989-11-16 1990-11-12 Osmotic, oral dosage form for fertility control

Publications (1)

Publication Number Publication Date
ATE96660T1 true ATE96660T1 (de) 1993-11-15

Family

ID=23736633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900649T ATE96660T1 (de) 1989-11-16 1990-11-12 Osmotische orale dosisform zur fertilitaetskontrolle.

Country Status (18)

Country Link
US (1) US5098714A (de)
EP (1) EP0500793B1 (de)
JP (1) JPH05501707A (de)
KR (1) KR920703024A (de)
AT (1) ATE96660T1 (de)
AU (1) AU640231B2 (de)
CA (1) CA2029647A1 (de)
DE (1) DE69004437T2 (de)
DK (1) DK0500793T3 (de)
ES (1) ES2060350T3 (de)
FI (1) FI922206A0 (de)
IE (1) IE62390B1 (de)
MX (1) MX174197B (de)
NO (1) NO921854L (de)
NZ (1) NZ236031A (de)
PT (1) PT95858B (de)
WO (1) WO1991007173A1 (de)
ZA (1) ZA909047B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
JP4334616B2 (ja) * 1994-09-22 2009-09-30 ナームローゼ・フエンノートチヤツプ・オルガノン 湿式粒状化による投与単位体を製造する方法
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US20110104214A1 (en) * 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
NZ591627A (en) 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
NZ545130A (en) * 2003-07-16 2009-03-31 Duramed Pharmaceuticals Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
AU2009240586A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
WO2014113693A1 (en) * 2013-01-18 2014-07-24 University Of Utah Research Foundation Modified release osmotic pump for ph-responsive intravaginal drug delivery
EP3031747B1 (de) * 2014-12-11 2018-10-10 Henkel IP & Holding GmbH Spenderpackung mit komprimierbaren schaum-/fasereinsätzen und verfahren zum variieren des ausgabevolumenverhältnis einer spenderpackung

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
NL271831A (de) * 1960-11-29
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
GB2010676B (en) * 1977-12-27 1982-05-19 Alza Corp Diffusional drug delivery device with block copolymer as drug carrier
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen

Also Published As

Publication number Publication date
ES2060350T3 (es) 1994-11-16
IE62390B1 (en) 1995-01-25
AU7786591A (en) 1991-06-13
DE69004437D1 (de) 1993-12-09
ZA909047B (en) 1991-09-25
IE904062A1 (en) 1991-05-22
FI922206L (fi) 1992-05-14
DK0500793T3 (da) 1994-01-03
EP0500793A1 (de) 1992-09-02
NO921854D0 (no) 1992-05-12
NZ236031A (en) 1993-05-26
PT95858B (pt) 1998-07-31
WO1991007173A1 (en) 1991-05-30
DE69004437T2 (de) 1994-03-03
AU640231B2 (en) 1993-08-19
JPH05501707A (ja) 1993-04-02
NO921854L (no) 1992-05-18
CA2029647A1 (en) 1991-05-17
MX174197B (es) 1994-04-27
FI922206A7 (fi) 1992-05-14
FI922206A0 (fi) 1992-05-14
US5098714A (en) 1992-03-24
KR920703024A (ko) 1992-12-17
PT95858A (pt) 1991-09-13
EP0500793B1 (de) 1993-11-03

Similar Documents

Publication Publication Date Title
ATE96660T1 (de) Osmotische orale dosisform zur fertilitaetskontrolle.
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
ATE175353T1 (de) Verfahren und system zur empfängnisverhütung
ATE239483T1 (de) Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption
NZ503890A (en) Oral contraceptives comprising non-uterotrophic anti-estrogens and progestin
AU5513494A (en) Compositions and methods of effecting contraception and control of breast cancer
DK0491415T3 (da) Orale svangerskabsforebyggende midler med lavt østrogen
AU3044892A (en) Hormone replacement therapy
ATE216241T1 (de) Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
HUP9901662A2 (hu) Gesztagén és ösztrogén kombinációjából álló kit és eljárás nőnemű emlősök fogamzásának gátlására
ATE213947T1 (de) Progestogen-anti-progestogen therapien
LU90341I2 (fr) 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
ATE271386T1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
ATE91410T1 (de) Osmotische dosierungsform.
NZ330603A (en) Hyaluronic acid derivatives used as cervical ripening agents
RU94040720A (ru) Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee